Polypharmacology: Principles and Methodologies [Hardcover] [Aug 02, 2022] Wang, Zhiguo and Yang, Baofeng

Wang, Zhiguo; Yang, Baofeng

ISBN 10: 3031049977 / ISBN 13: 9783031049972

Published by Springer, 2022

About this Item

A brand new book in pristine condition. Showing zero signs of shelf wear, creases, or damage.

Seller Inventory # SPRINGERNEW60432

Bibliographic Details

• Title: Polypharmacology: Principles and Methodologies [Hardcover] [Aug 02, 2022] Wang, Zhiguo and Yang, Baofeng
• Publisher: Springer
• Publication Date: 2022
• Language: English
• ISBN 10: 3031049977
• ISBN 13: 9783031049972
• Binding: Hardcover
• Condition: New

About this title

Synopsis

There is a growing interest in unmet needs for the development of a new discipline in drug discovery and in university education on polypharmacology. However, there has not been a book with the comprehensive compilation of basic knowledge and advanced methodology that is needed. This book aims to meet the needs making Polypharmacology a new sub-discipline of Pharmacology, not only being a hot area of pharmacological research and education but also a new paradigm for drug discovery. It contains the contents covering the entire scope of Polypharmacology including systemic in-depth exposition of basic knowledge, novel concepts, innovative technologies, and translational and clinical applications by showcasing state-of-the-art strategies and step-by-step instructions of cutting-edge methods. The contents of this book targets broad readerships including scientists in pharmacology research and drug development, and university teachers and graduates in medical school or school of pharmacy.

About the Author

 Zhiguo Wang PhD received his PhD in cardiovascular pharmacology from McGill University, Canada. He is presently the Director of the Division of Drug Discovery, Meditech Institute of Research and Advance (USA) and a Distinguished Professor in the Department of Pharmacology, Harbin Medical University. He is an author of over 150 research articles in prestigious scientific journals and of 6 monographs and 15 book chapters with renowned scientific publishers. His research interests cover cardiovascular disease and pharmacology, molecular pharmacology, epigenetic polypharmacology. His research group is one of the earliest investigators who proposed “one drug, multiple targets” polypharmacology concept and provided the experimental evidence in support of the epigenetic polypharmacology.